SciSparc Ltd. - ROE
SPRC
Price:
$7.41
Market Cap:
$428.59K
SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key drug candidates: SCI-110, which is being investigated for the treatment of Tourette syndrome, obstructive sleep apnea, and agitation associated with Alzheimer's disease; SCI-160, designed to address pain; and SCI-210, targeting autism spectrum disorder and epilepsy. The company has formed strategic alliances to further its goals. A partnership with Procaps focuses on the development and eventual commercial manufacturing of SCI-110, as well as CannAmide, an oral palmitoylethanolamide in a soft g...[Read more]
Industry
Biotechnology
IPO Date
2021-08-30
Stock Exchange
NASDAQ
Ticker
SPRC
PE Ratio
[0.08]
ROE
[-704.60%]
Current Ratio
[2.41]
Dividend Yield
[0%]
Enterprise Value
[-3796413.00]
Dividend History
The ROE as of June 2026 (TTM) for SciSparc Ltd. (SPRC) is -704.60%
According to SciSparc Ltd.’s latest financial reports and current stock price. The company's current ROE is -704.60%. This represents a change of -370.74% compared to the average of 260.25% of the last 4 quarters.
SciSparc Ltd. (SPRC) Historical ROE (quarterly & annually)
How has SPRC ROE performed in the past?
The mean historical ROE of SciSparc Ltd. over the last ten years is -4411.97%. The current -704.60% ROE has changed -84.03% with respect to the historical average. Over the past ten years (40 quarters), SPRC's ROE was at its highest in in the June 2025 quarter at 1.19%. The ROE was at its lowest in in the December 2019 quarter at -15464.29%.
Average
-4411.97%
Median
-161.16%
Minimum
-38300.00%
Maximum
-40.19%
SciSparc Ltd. (SPRC) ROE by Quarter and Year
Discovering the peaks and valleys of SciSparc Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.90%
Maximum Annual ROE = -40.19%
Minimum Annual Increase = -99.36%
Minimum Annual ROE = -38300.00%
| Year | ROE | Change |
|---|---|---|
| 2025 | -287.31% | 272.81% |
| 2024 | -77.07% | 14.56% |
| 2023 | -67.27% | 67.37% |
| 2022 | -40.19% | -43.60% |
| 2021 | -71.26% | -70.94% |
| 2020 | -245.24% | -99.36% |
| 2019 | -38300.00% | 731.34% |
| 2018 | -4607.03% | 5.90% |
| 2017 | -76.82% | -77.89% |
| 2016 | -347.53% | 79.94% |
SciSparc Ltd. (SPRC) Average ROE
How has SPRC ROE performed in the past?
The current ROE of SciSparc Ltd. (SPRC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-143.88%
5-year avg
-108.62%
10-year avg
-4411.97%
SciSparc Ltd. (SPRC) ROE vs. Peers
How is SPRC’s ROE compared to its peers?
SciSparc Ltd.’s ROE is greater than Indaptus Therapeutics, Inc. (-1028.81%), greater than Salarius Pharmaceuticals, Inc. (-395.42%), greater than Silexion Therapeutics Ltd. (-516.87%), greater than Lipella Pharmaceuticals Inc. (-208.44%), greater than Jasper Therapeutics, Inc. (-523.04%), greater than Onconetix, Inc. (-105.46%), greater than Azitra, Inc. (-251.51%), greater than Scinai Immunotherapeutics Ltd. (-30.05%), less than Protagenic Therapeutics, Inc. (184.88%), greater than Artelo Biosciences, Inc. (-1602.50%),
| Company | ROE | Market cap |
|---|---|---|
| -1028.81% | $6.83M | |
| -395.42% | $4.92M | |
| -516.87% | $1.14M | |
| -208.44% | $369.67K | |
| -523.04% | $7.36M | |
| -105.46% | $315.29K | |
| -251.51% | $1.84M | |
| -30.05% | $422.89K | |
| 184.88% | $742.18K | |
| -1602.50% | $2.94M |
Build a custom stock screener for SciSparc Ltd. (SPRC) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SciSparc Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
SciSparc Ltd. (SPRC) and other stocks custom spreadsheet templates
The easiest way to analyze a company like SciSparc Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is SciSparc Ltd.'s ROE?
How is the ROE calculated for SciSparc Ltd. (SPRC)?
What is the highest ROE for SciSparc Ltd. (SPRC)?
What is the 3-year average ROE for SciSparc Ltd. (SPRC)?
What is the 5-year average ROE for SciSparc Ltd. (SPRC)?
How does the current ROE for SciSparc Ltd. (SPRC) compare to its historical average?